it depends the order of the releases. if financial is first, it will dip, revenues are not so great, if fda news first, there will be a spike.but on any fda news (if it is good) it will pop.its all in the timing and order of the releases. if no releases,hold, this is a $1 stock. on the other hand if they can get off the pinks, its a $3 stock. imo